Under-reporting of TB cases and associated factors: a case study in China.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
11 Dec 2019
Historique:
received: 22 05 2019
accepted: 27 11 2019
entrez: 13 12 2019
pubmed: 13 12 2019
medline: 29 2 2020
Statut: epublish

Résumé

Tuberculosis is a leading cause of death worldwide and has become a high global health priority. Accurate country level surveillance is critical to ending the pandemic. Effective routine reporting systems which track the course of the epidemic are vital in addressing TB. China, which has the third largest TB epidemic in the world and has developed a reporting system to help with the control and prevention of TB, this study examined its effectiveness in Eastern China. The number of TB cases reported internally in two hospitals in Eastern China were compared to the number TB cases reported by these same hospitals in the national reporting systems in order to assess the accuracy of reporting. Qualitative data from interviews with key health officials and researcher experience using the TB reporting systems were used to identify factors affecting the accuracy of TB cases being reported in the national systems. This study found that over a quarter of TB cases recorded in the internal hospital records were not entered into the national TB reporting systems, leading to an under representation of national TB cases. Factors associated with underreporting included unqualified and overworked health personnel, poor supervision and accountability at local and national levels, and a complicated incohesive health information management system. This study demonstrates that TB in Eastern China is being underreported. Given that Eastern China is a developed province, one could assume similar problems may be found in other parts of China with fewer resources as well as many low- and middle-income countries. Having an accurate account of the number of national TB cases is essential to understanding the national and global burden of the disease and in managing TB prevention and control efforts. As such, factors associated with underreporting need to be addressed in order to reduce underreporting.

Sections du résumé

BACKGROUND BACKGROUND
Tuberculosis is a leading cause of death worldwide and has become a high global health priority. Accurate country level surveillance is critical to ending the pandemic. Effective routine reporting systems which track the course of the epidemic are vital in addressing TB. China, which has the third largest TB epidemic in the world and has developed a reporting system to help with the control and prevention of TB, this study examined its effectiveness in Eastern China.
METHODS METHODS
The number of TB cases reported internally in two hospitals in Eastern China were compared to the number TB cases reported by these same hospitals in the national reporting systems in order to assess the accuracy of reporting. Qualitative data from interviews with key health officials and researcher experience using the TB reporting systems were used to identify factors affecting the accuracy of TB cases being reported in the national systems.
RESULTS RESULTS
This study found that over a quarter of TB cases recorded in the internal hospital records were not entered into the national TB reporting systems, leading to an under representation of national TB cases. Factors associated with underreporting included unqualified and overworked health personnel, poor supervision and accountability at local and national levels, and a complicated incohesive health information management system.
CONCLUSIONS CONCLUSIONS
This study demonstrates that TB in Eastern China is being underreported. Given that Eastern China is a developed province, one could assume similar problems may be found in other parts of China with fewer resources as well as many low- and middle-income countries. Having an accurate account of the number of national TB cases is essential to understanding the national and global burden of the disease and in managing TB prevention and control efforts. As such, factors associated with underreporting need to be addressed in order to reduce underreporting.

Identifiants

pubmed: 31829147
doi: 10.1186/s12889-019-8009-1
pii: 10.1186/s12889-019-8009-1
pmc: PMC6907198
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1664

Références

Glob Health Action. 2017 Jan-Dec;10(sup1):1298890
pubmed: 28532305
PLoS One. 2012;7(2):e31076
pubmed: 22359565
Lancet. 2014 Jul 26;384(9940):347-70
pubmed: 24853604
BMC Health Serv Res. 2018 Oct 19;18(1):786
pubmed: 30340489
BMC Infect Dis. 2016 Dec 19;16(1):760
pubmed: 27993134
PLoS One. 2016 Feb 12;11(2):e0148449
pubmed: 26872353
PLoS One. 2015 Dec 07;10(12):e0144010
pubmed: 26641642
PLoS One. 2015 Sep 16;10(9):e0138274
pubmed: 26376197
Lancet. 2008 Nov 1;372(9649):1598-605
pubmed: 18930534
Vaccine. 2017 Aug 24;35(36):4702-4706
pubmed: 28750855
Int J Environ Res Public Health. 2015 Sep 07;12(9):11025-36
pubmed: 26371017
Health Aff (Millwood). 2011 Jan;30(1):127-35
pubmed: 21209448
Int Nurs Rev. 2018 Dec;65(4):515-523
pubmed: 29956822
Health Policy Plan. 2016 Sep;31 Suppl 2:ii35-ii46
pubmed: 27591205
Int J Tuberc Lung Dis. 2016 Oct;20(10):1334-1341
pubmed: 27725044
Global Health. 2017 Jul 31;13(1):49
pubmed: 28756767
Infect Dis Poverty. 2016 Jan 29;5:10
pubmed: 26822583
J Infect Dis. 2017 Nov 6;216(suppl_7):S724-S732
pubmed: 29117347

Auteurs

Danju Zhou (D)

Duke Global Health Institute, Duke University, Durham, NC, USA.

Michelle Pender (M)

Duke Global Health Institute, Duke University, Durham, NC, USA.

Weixi Jiang (W)

Duke Kunshan University, Kunshan, China.

Wenhui Mao (W)

Duke Global Health Institute, Duke University, Durham, NC, USA.

Shenglan Tang (S)

Duke Global Health Institute, Duke University, Durham, NC, USA.
Duke Kunshan University, Kunshan, China.
SingHealth Duke-NUS Global Health Institute, Singapore, Singapore.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH